High-dose interleukin-2 in metastatic renal cell carcinoma - Reply

被引：0
|
作者：
McDermott, DF [1 ]
Atkins, MB
Regan, MM
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 27期
关键词：
D O I：
10.1200/JCO.2005.02.2756
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6798 / 6799
页数：2
相关论文
共 50 条
  • [31] Treatment of metastatic renal cell carcinoma with low-dose interleukin-2
    Takezawa, Yuta
    Izumi, Kouji
    Nohara, Takahiro
    Narimoto, Kazutaka
    Ueno, Satoru
    Kadono, Yoshihumi
    Kitagawa, Yasuhide
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ANNALS OF ONCOLOGY, 2015, 26 : 145 - 145
  • [32] Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2
    David D. Stenehjem
    Michael Toole
    Joseph Merriman
    Kinjal Parikh
    Stephanie Daignault
    Sarah Scarlett
    Peg Esper
    Katherine Skinner
    Aaron Udager
    Srinivas Kiran Tantravahi
    David Gill
    Alli M. Straubhar
    Archana M. Agarwal
    Kenneth F. Grossmann
    Wolfram E. Samlowski
    Bruce Redman
    Neeraj Agarwal
    Ajjai Alva
    Cancer Immunology, Immunotherapy, 2016, 65 : 941 - 949
  • [33] Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2
    Stenehjem, David D.
    Toole, Michael
    Merriman, Joseph
    Parikh, Kinjal
    Daignault, Stephanie
    Scarlett, Sarah
    Esper, Peg
    Skinner, Katherine
    Udager, Aaron
    Tantravahi, Srinivas Kiran
    Gill, David
    Straubhar, Alli M.
    Agarwal, Archana M.
    Grossmann, Kenneth F.
    Samlowski, Wolfram E.
    Redman, Bruce
    Agarwal, Neeraj
    Alva, Ajjai
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (08) : 941 - 949
  • [34] Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data
    Ridolfi, L.
    Bulgarelli, J.
    Petracci, E.
    Pancisi, E.
    Piccinini, C.
    Granato, A.
    Petrini, M.
    Tazzari, M.
    Ancarani, V.
    Turci, L.
    Gentili, G.
    Valmorri, L.
    Romeo, A.
    De Giorgi, U. F. F.
    Burgio, S. L.
    Casadei, C.
    Cortesi, P.
    Lolli, C.
    De Rosa, F.
    Guidoboni, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [35] Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma
    Bulgarelli, Jenny
    Piccinini, Claudia
    Petracci, Elisabetta
    Pancisi, Elena
    Granato, Anna Maria
    de Rosa, Francesco
    Guidoboni, Massimo
    Petrini, Massimiliano
    Ancarani, Valentina
    Foschi, Giovanni
    Romeo, Antonino
    Tontini, Luca
    De Giorgi, Ugo
    Lolli, Cristian
    Gentili, Giorgia
    Valmorri, Linda
    Rossi, Alice
    Ferroni, Fabio
    Casadei, Carla
    Cortesi, Pietro
    Crudi, Laura
    Ridolfi, Laura
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [36] CARDIOPULMONARY TOXICITY OF TREATMENT WITH HIGH-DOSE INTERLEUKIN-2 IN 199 CONSECUTIVE PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CARCINOMA
    WHITE, RL
    SCHWARTZENTRUBER, DJ
    GULERIA, A
    MACFARLANE, MP
    WHITE, DE
    TUCKER, E
    ROSENBERG, SA
    CANCER, 1994, 74 (12) : 3212 - 3222
  • [37] Carbonic Anhydrase IX Expression Is Associated with Improved Outcome of High-dose Interleukin-2 Therapy for Metastatic Renal Cell Carcinoma
    Dudek, Arkadiusz Z.
    Yee, Ronald T.
    Manivel, Juan C.
    Isaksson, Rachel
    Yee, Heidi O.
    ANTICANCER RESEARCH, 2010, 30 (03) : 987 - 992
  • [38] Successful treatment of a patient on adrenal steroid replacement therapy high-dose bolus interleukin-2 for metastatic renal cell carcinoma
    Deshpande, H
    Dutcher, JP
    Novik, Y
    Oleksowicz, L
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (01): : 52 - 53
  • [39] Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?
    Dillman, Robert O.
    Barth, Neil M.
    VanderMolen, Louis A.
    Fong, Warren H.
    Mahdavi, Khosrow K.
    McClure, Stephanie E.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2011, 26 (03) : 273 - 277
  • [40] Clinical benefit (CB) of high-dose interleukin-2 (HD IL-2) in clear cell (cc) metastatic renal cell carcinoma (mRCC)
    Agarwal, Neeraj
    Parikh, Kinjal
    Tantravahi, Srinivas Kiran
    Crispin, Hilda
    Van Atta, Joan
    Batten, Julia Anne
    Sageser, Daniel
    Samlowski, Wolfram E.
    Grossmann, Kenneth F.
    Wang, Junfeng
    Stenehjem, David D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
12345